within April Organised by the
|
|
- Toby Blake
- 6 years ago
- Views:
Transcription
1 EFGCP Multi-Stakeholder Workshop &Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Wheree do we currently stand with the implementation in different Member States 13 April 2016 MCE Conference Centre Brussels, Belgium Organised by the European Forum for Good Clinical Practice In Partnership -
2 Introduction A revision of the Clinical Trials Regulation has been adopted by European legislation makers in This revised legal framework will bring significant advances compared to todays situation and is expected to be fully implemented as soon as the supporting Clinical Trials Portal and Database are fully functional (2H2017). The opportunity of the new Regulation to improve harmonisation and competitiveness of clinical research in Europe while safeguarding patients interests must be fully carried through at the national level to enable our region to emerge as an attractive place for conducting Clinical Research.This will not only benefit commercial and non-commercial sponsors, but specifically patients who are eagerly waiting to participate in Clinical Trials and benefit from new treatment options. The new legal rules specifically mandate a closer co-ordination of clinical trial applications assessments across EU Member States, supported by much closer collaboration between the national competent authorities and the ethics committees within each MemberState. EFGCP had hosted an initial workshop in September 2014 to discuss key implementation aspects with patients, academia, ethics committees, regulators and industry and share some good ideas and best practices to swiftly start the process in each country. This follow-on workshop aims now to show case the tremendous progress that has been made with the implementation over the past 18 months. The European Commission, for example, is facilitating discussions to resolve some key harmonisation questions across Europe. The EMA has made significant progress with the development of the new EU Clinical Trials Database and Portal which is the key working tool to facilitate a streamlined and swift coordination process between the various parties involved. In addition, Member States have started to develop new local procedures and initiated some early pilots to test the new assessment scenario. And finally Ethics Committees are intensifying or starting up new collaborations across countries to discuss important aspects of harmonisation of assessment criteria, methodologies and training of reviewers. Programme Committee Ingrid Klingmann Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium Hugh Davies Jozef Glasa Kim Champion Sini Eskola Angelika Joos Anastassia Negrouk Health Research Authority (HRA), United Kingdom Slovak Medical University/Institute of Medical Ethics & Bioethics, European Forum for Good Clinical Practice (EFGCP), Slovakia University College London (UCL), EFGCP, United Kingdom European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium Merck Sharp&Dohme, Belgium European Organisation for Research and Treatment of Cancer (EORTC), Belgium Faculty Péter Arányi Hungarian Ethics Committee for Clinical Pharmacology, Hungary Cristina Avendaño Solá Hospital Puerta de Hierro Majadahonda, Spain Marek Czarkowski Poland Hugh Davies Health Research Authority (HRA), United Kingdom Sini Eskola European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium Jan Geissler European Patients Academy on Therapeutic Innovation (EUPATI), Germany Jozef Glasa Slovak Medical University/Institute of Medical Ethics & Bioethics, European Forum for Good Clinical Practice (EFGCP), Slovakia Maja Leon Grzymkowska DG Health, European Commission Jörg Hasford Ludwig-Maximilians-University of Munich, Germany Kaisa Immonen- European Patients Forum (EPF), Belgium Charalambous Ann Marie Janson Lang Medical Products Agency (MPA), Sweden Angelika Joos Merck Sharp & Dohme, Belgium Page 2 of 5
3 Ingrid Klingmann François Lemaire Greet Musch Anastassia Negrouk Fabien Peuvrelle Claire Sibenaler Elke Stahl Fergus Sweeney Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium France Federal Agency for Medicines and Health Products, Belgium European Organisation for Research and Treatment of Cancer (EORTC), Belgium Celgene, Switzerland Les Entreprises du Médicament (LEEM), France Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Germany European Medicines Agency (EMA) Workshop Venue MCE Conference Centre Rue de l'aqueduc, Ixelles Belgium Tel: Website: Workshop Language The language of the workshop will be English. Registration & Information OPEN EVENT - conferences@efgcp.eu or visit Page 3 of 5
4 Agenda Wednesday 13 th April 09:00 Registration & Welcome Coffee 09:30 Welcome, General Introduction & Aim of the Day Ingrid Klingmann, Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium SESSION 1: General Status of the Regulation Implementation Chairs: Angelika Joos, Merck Sharp & Dohme, Belgium & Jan Geissler, European Patients Academy on Therapeutic Innovation (EUPATI), Germany 09:40 Keynote: Where do we stand with the implementation in Europe? Maja Leon Grzymkowska, DG Health, European Commission - What are the key questions for harmonization? - What is the implementation date? 09:55 Presentation of the Portal and Database and how it enables cooperation in the assessment and decision making process Fergus Sweeney, European Medicines Agency (EMA) - Where does the portal development stand? - How does the assessment process look in the system? - How are the various stakeholders participating? 10:25 Implementation across Europe: Summary from the EFPIA CTiMonitor quarterly survey Sini Eskola, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium 11:00 Coffee Break SESSION 2: Member State progress and early pilots Chairs: Hugh Davies, Health Research Authority (HRA), United Kingdom & Co-chair invited 11:20 The Future Approach to clinical trial application assessment How to coordinate a swift assessment? Presentations from: - François Lemaire, France - Speaker Invited, United Kingdom - Jörg Hasford, Ludwig-Maximilians-University of Munich,Germany - Greet Musch, Federal Agency for Medicines and Health Products, Belgium Followed by Q&A discussion with the audience 12:45 Lunch Break Page 4 of 5
5 Chairs: Anastasia Negrouk, European Organisation for Research and Treatment of Cancer (EORTC), Belgium & Fabien Peuvrelle, Celgene, Switzerland 13:45 The Future Approach to clinical trial application assessment How to coordinate a swift assessment? Presentations from: - Cristina Avendaño Solá, Hospital Puerta de Hierro Majadahonda, Spain - Speaker Invited, Italy - Ann Marie Janson Lang, Medical Products Agency (MPA), Sweden - Marek Czarkowski, Poland - Péter Arányi, Hungarian Ethics Committee for Clinical Pharmacology, Hungary Followed by Q&A discussion with the audience 15:10 Coffee Break SESSION 3: What else must be done to facilitate collaboration? Chairs: Jozef Glasa, Slovak Medical University/Institute of Medical Ethics & Bioethics, European Forum for Good Clinical Practice (EFGCP), Slovakia & Ingrid Klingmann, Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium 15:30 Panel discussion about pilot experience, ethic committee collaborations, sharing of best practices, training of assessors Panelists: Claire Sibenaler, Les Entreprises du Médicament (LEEM), France Kaisa Immonen-Charalambous, European Patients Forum (EPF), Belgium Elke Stahl, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Germany 16:55 Conclusions & Next Steps Ingrid Klingmann, Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium 17:00 End of Workshop Page 5 of 5
within April Organised by the With
EFGCP Multi-Stakeholder Workshop & Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Wheree do we currently stand with the implementation in different Member
More informationOptions and Challenges for Ethical Assessment in the Clinical Trial Regulation Proposal
EFGCP Workshop on Options and Challenges for Ethical Assessment in the Clinical Trial Regulation Proposal Road Map Initiative for Clinical Research in Europe Husa President Hotel, Brussels, Belgium 7 &
More informationA Multi-Stakeholder Workshop of the Joint EFGCP-MedTech Europe Medical Technology Working Party on
A Multi-Stakeholder Workshop of the Joint EFGCP-MedTech Europe Medical Technology Working Party on Mitigating Risks in the Lifecycle of Medical Devices: Options and Challenges in Building Clinical Evidence
More informationEUPATI 2013 CONFERENCE EUPATI: A VISION FOR 2020
EUPATI 2013 CONFERENCE EUPATI: A VISION FOR 2020 19 April 2013, Hilton Rome Airport Hotel, Rome Airport Fiumicino, Italy Introduction The EUPATI consortium is delighted to announce its first EUPATI conference
More informationExplore Ways to Enhance Collaboration Between Key Players
Joint EFGCP / DIA / EMA Better Medicines for Children Conference 2014 on Explore Ways to Enhance Collaboration Between Key Players 30 th September & 1 st October 2014 EMA, London, United Kingdom Organised
More informationTaking forward reform of the EU Clinical Trials Directive. Introduction
Taking forward reform of the EU Clinical Trials Directive Introduction Implementation of the Clinical Trials Directive (CTD), intended to harmonise authorisation of EU clinical trials on medical products,
More informationEMA/HMA/EC workshop on electronic Product Information (epi)
EMA/HMA/EC workshop on electronic Product Information (epi) Improving access to the EU medicines product information Wednesday, 28 November 2018 European Medicines Agency London, United Kingdom Background
More informationNETWORKING OF EUROPEAN REC`S. Dirk Lanzerath EUREC, Secretary General
NETWORKING OF EUROPEAN REC`S Dirk Lanzerath EUREC, Secretary General First steps of EUREC based on 2001 EC Directive on good clinical practice in the conduct of clinical trials on medicinal products for
More informationBiomarkers and Patient s Access to Personalized Oncology Drugs in Europe
CDDF Cancer Drug Development Forum CDDF MULTI - STAKEHOLDER WORKSHOP Biomarkers and Patient s Access to Personalized Oncology Drugs in Europe Brussels, Belgium 24-25 September 2018 PROGRAMME PROGRAMME
More informationA regulatory update in a day for Small to Medium-sized Enterprises
TOPRA ANNUAL SYMPOSIUM STOCKHOLM, SWEDEN In partnership with the Swedish Medical Products Agency Time of transformation: Implementing international regulatory change A regulatory update in a day for Small
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 18 th International Conference on Medicinal and Pharmaceutical Chemistry October 18-19, 2018, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote
More informationProgramme. Ethics in Regulatory Affairs for Pharmaceutical Products: dilemmas in decision-makings. Preliminary version ( )
Location: MAERSK TOWER (Room 13.1.63 - OBS! 4 TH of October Room 7.15.122) Programme Ethics in Regulatory Affairs for Pharmaceutical Products: dilemmas in decision-makings 3 rd 6 th October 2017 Preliminary
More informationENVIRONMENTAL RISK ASSESSMENTS: EU CLINICAL TRIALS WITH GMO-BASED ATMPS ANN GORMAN, AMGEN LTD, UK 16 DECEMBER 2016
ENVIRONMENTAL RISK ASSESSMENTS: EU CLINICAL TRIALS WITH GMO-BASED ATMPS ANN GORMAN, AMGEN LTD, UK 16 DECEMBER 2016 SIMPLIFIED DEFINITIONS Genetically Modified Organism (GMO)? An organism, e.g virus, plant,
More informationClinical Trials Environment EU Legislation: Ausblick auf die neue Gesetzgebung für klinische Prüfungen
The Future of the Regulatory Berlin, 31.05.2013 Clinical Trials Environment EU Legislation: Qualifizierungstag für Study Nurses Ausblick auf die neue Gesetzgebung für klinische Prüfungen Dr. med. Ingrid
More informationMaking the case for Personalised Medicine
Making the case for Personalised Medicine The biopharmaceutical industry perspective Barbara Freischem Executive Director European Biopharmaceutical Enterprises Who we are EBE represents the voice of biopharmaceutical
More informationSession 13: Prequalification Within the Context of Global Fund Procurements
Session 13: Prequalification Within the Context of Global Fund Procurements Established in 2002 Global Fund Attracts and disburses additional resources to prevent and treat AIDS, tuberculosis (TB), and
More informationEuropean Pharmaceutical Policy: Access for Patients or Improving Competitiveness
European Pharmaceutical Policy: Access for Patients or Improving Competitiveness The s Vision Dr Stefaan Van der Spiegel Policy Officer, Unit F5 DG Enterprise and Industry Study day OSE / RIZIV-INAMI Brussels,
More informationEudraVigilance Expert Working Group (EV-EWG) work programme 2018
06 February 2018 EMA/428950/2017 Rev. 1 Inspections & Human Medicines Pharmacovigilance EudraVigilance Expert Working Group (EV-EWG) work programme 2018 30 Churchill Place Canary Wharf London E14 5EU United
More informationEU Innovation Network
EMA Roundtable Meeting, London, 27 November, 2015 >>www.pei.de EU Innovation Network Federal Agency for Vaccines and Biomedicines Bettina Ziegele - Start 2001: ITF at EMA 2008-2011: first innovation offices
More informationInformation points report
ESCO (2015) SEC 073 FINAL Creation Date: 16/07/2015 Last update: 15/09/2015 Information points report Purpose of the document The purpose of this document is to brief the ESCO Maintenance Committee (MAI)
More informationReview of EU Clinical Trial Directive. 15 May 2012 Mike Beckers Sidley Austin LLP, Brussels
BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK PALO ALTO SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. Review of EU Clinical Trial Directive 15
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 9 th World Congress on Bioavailability & Bioequivalence April 16-18, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme aims
More informationFACILITATION OF THE ENTRY INTO FORCE AND HARMONIZED INTERPRETATION OF THE HNS PROTOCOL, 2010
E LEGAL COMMITTEE 102nd session Agenda item 3 LEG 102/3/2 2 March 2015 Original: ENGLISH FACILITATION OF THE ENTRY INTO FORCE AND HARMONIZED INTERPRETATION OF THE HNS PROTOCOL, 2010 Report of a Workshop
More informationEEA resource efficiency webinar, 4 Dec 2015
EEA resource efficiency webinar, 4 Dec 2015 More from less and 2015 review of material resource efficiency policies in 31 countries Welcome - will start at 12:30 sharp Here you can adjust the size of display
More informationActivities of the Korean Association of the Institutions Review Boards (KAIRB) in the year of Korea
Activities of the Korean Association of the Institutions Review Boards (KAIRB) in the year of 2002-2003 Korea October 18, 2003 Ock-Joo Kim, M.D., Ph.D. General Secretary of KAIRB (Seoul, Korea) I. Foundation
More informationUpdate on the IMI2 Proposal to Build a Sustainable pan- European Paediatric Clinical Trials Network
Update on the IMI2 Proposal to Build a Sustainable pan- European Paediatric Clinical Trials Network William R Treem, M.D.;* Child Health Innovation and Leadership Department, Johnson and Johnson October
More informationMechanism of coordinated access to Orphan Medicinal Products. MoCA. NIHDI Belgium
Mechanism of coordinated access to Orphan Medicinal Products MoCA dr Ri DeRidder NIHDI Belgium Context The Issue: Delays and disparities in access to OMP s Decisions on Pricing and Reimbursement exclusive
More informationEU Regulatory Perspective
EU Regulatory Perspective Sensible Guidelines. Fergus Sweeney, Head, Compliance and Inspections, European Medicines Agency An agency of the European Union Disclaimer The views presented in this presentation/these
More informationTechnical assistance tools and public support schemes to exploit resource efficiency potential in SMEs
Technical assistance tools and public support schemes to exploit resource efficiency potential in SMEs Tuesday 22nd May 2018 Ministry of Industry and Trade, Prague, Czech Republic ABOUT THE WORKSHOP Event
More informationCONFERENCE PROGRAMME May
CONFERENCE PROGRAMME 18 19 May 2017 PROGRAMME COMMITTEE AGAH, Germany: Dr Kerstin Breithaupt, Dr Ingrid Klingmann, Professor Hildegard Sourgens AHPPI, UK: Dr Michael Hammond, Dr Ulrike Lorch, Dr Jorg Taubel
More informationINTERNATIONAL CONFERENCE. Socio-economic Impacts of Biofuels and Bio-products
INTERNATIONAL CONFERENCE Socio-economic Impacts of Biofuels and Bio-products Final Conference of the Global-Bio-Pact Project Brussels - Belgium 29-30 January 2013 Programme (Status: 29 November 2012) Conference
More informationWP Inspection Competence of Authorities
WP Inspection Competence of Authorities Eva G. Friberg (chair) and Steve Ebdon-Jackson 1 Action Plan Tasks: Survey on clinical competence 2012 Clinical training courses for Inspectors in UK 2014 HERCA
More informationPediatric drug development - do we need a PIP so early in development? American versus European approach
Pediatric drug development - do we need a PIP so early in development? American versus European approach Angelika Joos Executive Director, Global Regulatory Policy Merck Sharp & Dohme (Europe) Inc., Brussels
More informationEU-RUSSIA ENERGY DIALOGUE
EU-RUSSIA ENERGY DIALOGUE Thematic Group on Energy Efficiency REPORT 2010 (SECOND HALF 2008 SECOND HALF 2010) INTRODUCTION Cooperation on energy efficiency, energy savings and renewable energy is an important
More informationMODULE 12 Regulatory affairs April 2017 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES
MODULE 12 Regulatory affairs 26-27 April 2017 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES n DRUG REGISTRATION : EUROPEAN PROCEDURES AND INTERNATIONAL ENVIRONMENT
More informationCitation for the original published paper (version of record):
http://www.diva-portal.org Postprint This is the accepted version of a paper published in Patient. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal
More informationENVIRONMENT. Achieving CONCEPT PAPER
ASIA SIA-EUROPE ENVIRONMENT FORUM 5 TH ROUNDTABLE Achieving Urban Sustainability: Integrated Environmental Management 28-30 November Shenzhen, China CONCEPT PAPER SUMMARY A roundtable discussion among
More information26 June 2017 Maison des Associations Internationales rue Washington, 40 B-1050 Bruxelles, Belgium
EU-funded Project Capacity4Rail Interactive Workshop A New Competitive, Reliable, Sustainable and Connected Rail Freight Transport rue Washington, 40 Detailed Programme & Practical Information An event
More informationAGENDA MENA-OECD STEERING GROUP MEETING. MENA-OECD Initiative on Governance. 3 May 2010 Paris, France. Website:
AGENDA 3 May 2010 Paris, France MENA-OECD STEERING GROUP MEETING MENA-OECD Initiative on Governance and Investment 2009 MENA-OECD for Development Website: www.oecd.org/mena MENA-OECD STEERING GROUP MEETING
More informationLSE Health Market Access Academy April 2018, London September 2018, London
LSE Health Market Access Academy 9 13 April 2018, London 10 14 September 2018, London In cooperation with the Boston Consulting Group Market Access Roundtable LSE Health Market Access Academy 2 The London
More information4th annual LONDON SPONSORSHIP BROCHURE. Get in touch with James Taylor to discuss bespoke packages -
4th annual LONDON SPONSORSHIP BROCHURE Get in touch with James Taylor to discuss bespoke packages - jtaylor@fintecnet.com Focus for RBI EU 2019 In 2019, RBI EU 2018 will continue to focus on the digital
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 10 th International Tissue Repair and Regeneration Congress June 13-14, 2019 Helsinki, Finland our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 29.06.2005 COM(2005) 286 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE COMMITTEE OF THE REGIONS AND THE EUROPEAN ECONOMIC
More informationEUCERD RECOMMENDATION FOR A
EUCERD RECOMMENDATION FOR A CAVOMP INFORMATION FLOW RECOMMENDATION OF THE EUROPEAN UNION COMMITTEE OF EXPERTS ON RARE DISEASES TO THE EUROPEAN COMMISSION AND THE MEMBER STATES ON IMPROVING INFORMED DECISIONS
More informationPersonalised Medicine Conference 2016
Personalised Medicine Conference 2016 1-2 June 2016, Brussels Ruxandra DRAGHIA-AKLI European Union, 2016 Image sources: Raman Khilchyshyn #70301568, Anthonyc #78062504, robu_s #90937022, Kamaga #774676758,
More informationPublic Consultation on the European Solidarity Corps
Contribution ID: 2d9b4621-cc4d-4c64-a5af-13acac98b4fe Date: 31/03/2017 17:04:55 Public Consultation on the European Solidarity Corps Fields marked with * are mandatory. Introduction The European Solidarity
More informationCredit Guarantee Schemes: Regulation and Management
PUTTING IN PLACE THE CONDITIONS TO SET UP A CREDIT GUARANTEE SCHEME FOR AGRIBUSINESS SMEs IN UKRAINE Credit Guarantee Schemes: Regulation and Management Capacity Building Seminars 22-24 February 2016 Ministry
More informationThe 24 th Autumn Introductory Course: Target the Heart of European Regulatory Affairs *Preliminary Programme
The 24 th Autumn Introductory Course: Target the Heart of European Regulatory Affairs *Preliminary Programme Prague, Czech Republic Vienna House Andel s Prague Stroupeznickeho 21, 15000 Prague, Czech Republic
More informationEU Perspective on Regulatory Issues for Biologics
Oncology Biologics Development Primer 29 February 2008 Robert Charnas Disclosure Employee and shareholder of Amgen, Inc. Thousand Oaks, CA Worked in Basel, Switzerland for 19 Years and dealt with European
More informationThe 23 rd Autumn Introductory Course:
The 23 rd Autumn Introductory Course: Target the Heart of European Regulatory Affairs Prague, Czech Republic Sheraton Prague Charles Square hotel Zitna 561/8, Prague 13-17 November 2017 Monday 13 November
More informationGlobal Clinical Trials Transparency Conference September 2018
Global Clinical Trials Transparency Conference 19-20 September 2018 Pre-Conference Workshop : The Evolving Disclosure/Transparency Landscape 18 September 2018 Doubletree by Hilton Docklands Riverside London,
More informationDraft Agenda. Wednesday, 14 March Alexander Natz, Secretary General, EUCOPE Maarten Meulenbelt, Partner, Sidley Austin LLP
Wednesday, 14 March 2012 10:00 Welcoming Remarks 10:00 10:30 EU Pharmaceutical Case Law Overview of recent Pharmaceutical case-law Perspective of the Legal Service Impact to life sciences industry Markéta
More informationEUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL
EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Health systems, medical products and innovation Medicines: policy, authorisation and monitoring PHARM 723 PHARMACEUTICAL COMMITTEE 18 October
More informationWorkshop on Access to and Uptake of Biosimilar Medicinal Products
EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Consumer, Environmental and Health Technologies Biotechnology and Food Supply Chain Workshop on Access to
More informationThe FMD Pack Coding, Sharing and Transition
The FMD Pack Coding, Sharing and Transition Ask the expert Joan Cahill & Grant Courtney April 2017 Introduction Joan Cahill Director, Pfizer Packaging & Delivery Systems Member EFPIA Supply Chain Working
More information2008 Pharmaceutical Package - Impact on Implementation by BfArM
2008 Pharmaceutical Package - Impact on Implementation by BfArM Dr. Karl Broich Head of Licensing Division 4, German Alternate at CHMP Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee
More informationWaste prevention in Europe. European Environment Agency
Waste prevention in Europe Özgür Saki European Environment Agency The European Environment Agency An EU institution situated in Copenhagen since 1994 Provides the information necessary to enable policy
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL ENVIRONMENT Directorate C - Quality of Life, Water & Air
EUROPEAN COMMISSION DIRECTORATE-GENERAL ENVIRONMENT Directorate C - Quality of Life, Water & Air DIRECTORATE-GENERAL INTERNAL MARKET AND SERVICES Directorate C Public Procurement Multi-stakeholder Dialogue
More informationEuropean Epidemiological Forum
European Epidemiological Forum Observational Research and Pharmacoepidemiology in Europe: deeper insights to drive health research and discovery Amsterdam,The Netherlands Hyatt Place Amsterdam Airport
More informationMinutes of the ninth meeting of the EMA Human Scientific Committees Working Party with Patients' and Consumers' Organisations (PCWP)
17 March 2010 EMA/625710/2009 Minutes of the ninth meeting of the EMA Human Scientific Committees Working Party with Patients' and Consumers' Organisations (PCWP) 30 September 2009 Role Chairpersons: Present:
More informationEHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES. Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium
EHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium Electronic Health Records for Clinical Research Re-use of EHR data for optimizing Clinical
More informationPublication of Risk Management Plan (RMP) summaries:
Publication of Risk Management Plan (RMP) summaries: Analysis of the experience of the 1-year pilot phase Presented by Juan Garcia Burgos and Caroline Voltz An agency of the European Union Outline Background
More informationFirst Plenary Session CONVERGING OR DIVERGING MODELS OF HTA IN EUROPE. Jean-Luc Harousseau, MD
First Plenary Session Speaker CONVERGING OR DIVERGING MODELS OF HTA IN EUROPE Jean-Luc Harousseau, MD President and Chairman of the Board Haute Autorité de Santé (HAS) Saint-Denis La Plaine, France HTA
More informationPharmacovigilance- Content of the New EU Legislation and Challenges for BfArM
Pharmacovigilance- Content of the New EU Legislation and Challenges for BfArM 12 th DGRA Annual Congress June 15 to 16, Bonn U. Hagemann Bundesinstitut für Arzneimittel und Medizinprodukte BfArM Visit
More informationLEO Pharma Commercial Excellence EU+
LEO Pharma Commercial Excellence EU+ Geomarketing Praxistag Health 12. März 2018 Karsten Schmidt, Director Commercial Excellence, LEO Pharma March 12, 2018 Commercial Excellence Karsten Schmidt, LEO Pharma
More informationE O. The EORTC Strategy for New Drug Development THE EORTC PROVIDES: The EORTC is the leading pan-european partner for high-quality clinical research
The EORTC Strategy for New Drug Development The EORTC is the leading pan-european partner for high-quality clinical research E O RT C THE EORTC PROVIDES: A NETWORK OF HIGH-QUALITY, DEDICATED CLINICAL RESEARCHERS
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES International Conference on Biomaterials for Bone Tissue Engineering March 18-19, 2019 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our
More informationThe Learning Health System in Europe
The Learning Health System in Europe International conference SEPTEMBER 24 th +25 th, 2015 Brussels, Belgium TRANSFoRm What is the Learning Health System? The concept of a Learning Health System (LHS)
More informationLet us join hands with PvPI to ensure patient safety ADR Reporting Helpline (Toll Free):
Regional Workshop on "Basics of Pharmacovigilance & Establishment of Pharmacovigilance System in Pharmaceutical Industries - A Way Forward" June 23, 2017 - AIIMS, Rishikesh (10:30 AM to 04:00 PM) Last
More informationMS- Customer Feedback Survey. 64th Advisory Forum Meeting, EFSA, 8-9 June 2017
MS- Customer Feedback Survey 64th Advisory Forum Meeting, EFSA, 8-9 June 2017 WHY Customer Feedback is considered a valuable input in striving for continuous improvement, as defined by the EFSA Strategy
More informationADDRESSING THE ENERGY-WATER NEXUS THROUGH R&D PLANNING AND POLICIES
IEA Committee on Energy Research and Technology EXPERTS GROUP ON R&D PRIORITY-SETTING AND EVALUATION ADDRESSING THE ENERGY-WATER NEXUS THROUGH R&D PLANNING AND POLICIES An event organised under the auspices
More informationWorkshop EERA Joint Programme on Energy Efficiency in Industrial Processes SINTEF office in Brussels Rue de Trone, 61 Brussels, 16 June 2016
Workshop EERA Joint Programme on Energy Efficiency in Industrial Processes SINTEF office in Brussels Rue de Trone, 61 Brussels, 16 June 2016 Borana Taraj, Project Officer, Research & Innovation, EUA This
More informationFederal agency for medicines and health products
Federal agency for medicines and health products The implementation of the EU CT Regulation : Overview of the different projects in progress Greet Musch KCE Symposium, 12 th October 2016 1: Overview of
More informationGlobal Pharma Summit
allied academies Global Pharma Summit September 03-04, September 03-04 Theme: Advanced Pharma Technologies-Better Healthcare system Sponsorship For More Details For Queries pharmaceutical@alliedmeetings.com
More informationAGENDA: Joint BWP/QWP workshop with stakeholders in relation to prior knowledge and its use in regulatory applications
22 November 2017 EMA/CHMP/BWP/149179/2017 Human Medicines Research and Development Support Division AGENDA: Joint BWP/QWP workshop with stakeholders in relation to prior knowledge and its use 23 November
More informationEUCROF Presentation. EMA Roundtable meeting with stakeholders on the 10-year anniversary of the SME Office. 27 November 2015 London
EUCROF Presentation EMA Roundtable meeting with stakeholders on the 10-year anniversary of the SME Office 27 November 2015 London Dr. Stefano Marini, MD EUCROF President European Contract Research Organization
More informationOrganised by the European Commission. 27 and 28 November in the City of Rotterdam, the Netherlands
3 rd CITIES FORUM Organised by the European Commission 27 and 28 November in the City of Rotterdam, the Netherlands Moving forward with the Urban Agenda for the EU towards a more sustainable urban development
More informationKickstarting the Brain: Regulatory Aspects of New Emerging Technologies
Kickstarting the Brain: Regulatory Aspects of New Emerging Technologies Prof. Dr. med. Karl Broich Prof. Dr. K. Broich New Therapies ISCTM, September 2016 Page 1 Agenda Is a CE mark sufficient? Differences
More informationBDA WORKSHOP PROGRAMME. HOW TO MATURE EMERGING TECHNOLOGIES INTO COMPANION DIAGNOSTICS December 2013 BRUSSELS, BELGIUM
BDA WORKSHOP HOW TO MATURE EMERGING TECHNOLOGIES INTO COMPANION DIAGNOSTICS 12-13 December 2013 BRUSSELS, BELGIUM PROGRAMME BIOTHERAPY DEVELOPMENT ASSOCIATION Content The Biotherapy Development Association
More informationOECD Eurasia Competitiveness Roundtable
With the financial support of the European Union DRAFT AGENDA OECD Eurasia Competitiveness Roundtable Peer Review of Competitiveness Reforms in the Kyrgyz Republic and the Republic of Moldova 4 December
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL PUBLIC CONSULTATION
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Healthcare systems Health systems and products PUBLIC CONSULTATION Brussels, 31 July 2012 on the modalities of stakeholder consultation in the
More informationComments from: Leem (Les entreprises du Médicament)
Submission of comments on 'Guidelines on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use Comments
More informationEFPIA layperson summary Principles that apply to Clinical Trial Transparency. Antonio Ferrari (Chiesi) & Solange Rohou (AZ)
EFPIA layperson summary Principles that apply to Clinical Trial Transparency. Antonio Ferrari (Chiesi) & Solange Rohou (AZ) Disclaimer I am an employee of Chiesi Farmaceutici s.p.a (Head of Clinical Safety
More informationHouse of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data
House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data Evidence submitted by the Medical Research Council, 26 February 2013 Introduction 1. The Medical Research
More informationThe Learning Health System in Europe
The Learning Health System in Europe International conference SEPTEMBER 24 th +25 th, 2015 Brussels, Belgium TRANSFoRm What is the Learning Health System? The concept of a Learning Health System (LHS)
More informationCertification in Pharmaceutical Medicine and Clinical Research The vision of regulators
Certification in Pharmaceutical Medicine and Clinical Research The vision of regulators Presented by Sergio Bonini Professor of Medicine, Second University of Naples Expert-on-Secondment, European Medicine
More informationEditor : Francoise SCHLEMMER Date : 09/03/2015 IMDRF, March 9 th 2015 REPORT Present : Hans-Heiner Junker Francoise SCHLEMMER
The European Association Medical Devices - Notified Bodies TEAM-NB A.I.S.B.L. Boulevard Frère Orban 35A B 4000 Liège BELGIQUE Tél.: + 32 (0)4 254 55 88 Fax: + 32 (0)4 254 55 89 E-mail: secretary@team-nb.org
More informationWorldDAB Automotive May, 2016 AutoWorld, Brussels, Belgium. Sponsorship, exhibition and advertising opportunities
WorldDAB Automotive 2016 11 May, 2016 AutoWorld, Brussels, Belgium Sponsorship, exhibition and advertising opportunities 1 WorldDAB Automotive 2016 Digital Radio Leaders Meet Here To AUDI, one of the leading
More informationPublication of Risk Management Plan (RMP) summaries:
Publication of Risk Management Plan (RMP) summaries: Analysis of the experience of the 1-year pilot phase PCWP meeting November 2015 An agency of the European Union Why produce a Summary of the Risk Management
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. Health systems and products Medicinal products authorisations, EMA Head of Unit
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products authorisations, EMA Head of Unit PHARM 606 PHARMACEUTICAL COMMITTEE 28 March 2012 68 th meeting
More informationGuidelines and Information for Bids for Organizing a AAATE Conference
Last update 22.1.2018 pg 1/7 Guidelines and Information for Bids for Organizing a AAATE Conference 1. Introduction AAATE, the Association for the Advancement of Assistive Technology in Europe, delivers
More informationMinutes of the sixth partner meeting in Verona from the 26 th to the 28 th of April 2010
Minutes of the sixth partner meeting in Verona from the 26 th to the 28 th of April 2010 Participants Henriette Hansen Arne Gårn Anette Nielsen Anette Reinholdt Mikael Sorknæs Eva Bellsund Thomas Falk
More informationEU health policy. Strategy for the pharmaceutical industry and biosimilars. Salvatore D'Acunto. DG Research. DG Internal Market. DG Health & Consumers
Strategy for the pharmaceutical industry and biosimilars Salvatore D'Acunto European Commission Enterprise and Industry Directorate-General London, 3 April 2014 EU health policy DG Research R&D, innovation
More informationAvailability of human medicinal products in Europe how big is the problem and what can we do?
Availability of human medicinal products in Europe how big is the problem and what can we do? Kristin Raudsepp Director General Estonian State Agency of Medicines The presentation Initiative by the regulators
More informationThe Situation of Investigator Initiated Trials in Europe. Dr.N.Gökbuget
The Situation of Investigator Initiated Trials in Europe Dr.N.Gökbuget Investigator Initiated Trials in Europe Difficulties and Possibilities 1. Situation for academic clinical trials after the EU directive
More informationDESIGNING AND DELIVERING SKILLS STRATEGIES FOR CITIES. Capacity Building Seminar for Partnerships June 2008, Trento, Italy.
Organisation for Economic Co-operation and Development Local Economic and Employment Development Programme DESIGNING AND DELIVERING SKILLS STRATEGIES FOR CITIES Agenda Venue OECD LEED Trento Centre for
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health systems, medical products and innovation Medicines: policy, authorisation and monitoring STAMP 4/24 Record STAMP Commission Expert
More informationSupporting Decentralisation in Ukraine:
AGENDA Supporting Decentralisation in Ukraine: Enhancing local civil service performance for effective public service delivery Friday 2 March 2018 10:00 18:00 Intercontinental Hotel Kyiv 2A Velyka Zhytomyrska
More information